MPEG1 Human Pre-designed siRNA Set A contains three designed siRNAs for MPEG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MPG Human Pre-designed siRNA Set A contains three designed siRNAs for MPG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

mPGES-1-IN-2 (compound III) is a benzimidazole-based mPGES-1 inhibitor that also inhibits adipophysin PGD synthase (I-PGDS) (5 μM, IR=60 %). mPGES-1-IN-2 reduces PGE2 production and tends to reduce levels of other prostaglandins. mPGES-1-IN-2 effectively inhibits acute inflammation in an air sac model stimulated by Carrageenan (HY-125474) in mice[1].

mPGES-1-IN-2 (compound III) is a benzimidazole-based mPGES-1 inhibitor that also inhibits adipophysin PGD synthase (I-PGDS) (5 μM, IR=60 %). mPGES-1-IN-2 reduces PGE2 production and tends to reduce levels of other prostaglandins. mPGES-1-IN-2 effectively inhibits acute inflammation in an air sac model stimulated by Carrageenan (HY-125474) in mice[1].

mPGES-1-IN-2 (compound III) is a benzimidazole-based mPGES-1 inhibitor that also inhibits adipophysin PGD synthase (I-PGDS) (5 μM, IR=60 %). mPGES-1-IN-2 reduces PGE2 production and tends to reduce levels of other prostaglandins. mPGES-1-IN-2 effectively inhibits acute inflammation in an air sac model stimulated by Carrageenan (HY-125474) in mice[1].

mPGES-1-IN-2 (compound III) is a benzimidazole-based mPGES-1 inhibitor that also inhibits adipophysin PGD synthase (I-PGDS) (5 μM, IR=60 %). mPGES-1-IN-2 reduces PGE2 production and tends to reduce levels of other prostaglandins. mPGES-1-IN-2 effectively inhibits acute inflammation in an air sac model stimulated by Carrageenan (HY-125474) in mice[1].

mPGES-1-IN-2 (compound III) is a benzimidazole-based mPGES-1 inhibitor that also inhibits adipophysin PGD synthase (I-PGDS) (5 μM, IR=60 %). mPGES-1-IN-2 reduces PGE2 production and tends to reduce levels of other prostaglandins. mPGES-1-IN-2 effectively inhibits acute inflammation in an air sac model stimulated by Carrageenan (HY-125474) in mice[1].

mPGES-1-IN-2 (compound III) is a benzimidazole-based mPGES-1 inhibitor that also inhibits adipophysin PGD synthase (I-PGDS) (5 μM, IR=60 %). mPGES-1-IN-2 reduces PGE2 production and tends to reduce levels of other prostaglandins. mPGES-1-IN-2 effectively inhibits acute inflammation in an air sac model stimulated by Carrageenan (HY-125474) in mice[1].

MPHOSPH8 Human Pre-designed siRNA Set A contains three designed siRNAs for MPHOSPH8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MPHOSPH9 Human Pre-designed siRNA Set A contains three designed siRNAs for MPHOSPH9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MPI Human Pre-designed siRNA Set A contains three designed siRNAs for MPI gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MPI-0441138 is an inducer of apoptosis and an inhibitor of mitosis. MPI-0441138 can induce DNA breaks and induce cytochrome c translocation, leading to tumor cell death[1].

MPIG6B Human Pre-designed siRNA Set A contains three designed siRNAs for MPIG6B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MPL Human Pre-designed siRNA Set A contains three designed siRNAs for MPL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Mpl Mouse Pre-designed siRNA Set A contains three designed siRNAs for Mpl gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Mpl Rat Pre-designed siRNA Set A contains three designed siRNAs for Mpl gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

MPLKIP Human Pre-designed siRNA Set A contains three designed siRNAs for MPLKIP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MPND Human Pre-designed siRNA Set A contains three designed siRNAs for MPND gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MPO Antibody is an unconjugated, approximately 84 kDa, mouse-derived, anti-MPO monoclonal antibody. MPO Antibody can be used for: WB, IHC-P, IF-Cell, IF-Tissue expriments in human, mouse, rat background without labeling.

MPO Human Pre-designed siRNA Set A contains three designed siRNAs for MPO gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MPO-IN-6 (compound ADC) is an electrophile with good antioxidant and anti-inflammatory properties. MPO-IN-6 is a myeloperoxidase (MPO), dipeptidyl peptidase-4 (DPP-4), and α-glucosidase (α-GD) inhibitor with IC50s of 10 μM, 31.02 μM, and 46.05 μM, respectively. MPO-IN-6 is a potential cardiovascular preventive agent[1].

MPO-IN-7 (compound MDC) is a myeloperoxidase inhibitor with the IC50 values of 41 μM, 25 μM and 4.5 μM towards α-Glucosidase, dipeptidyl peptidase-4 and myeloperoxidase, respectively. MPO-IN-7 shows antioxidant and anti-inflammatory activity in vitro[1].

MPP1 Human Pre-designed siRNA Set A contains three designed siRNAs for MPP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MPP2 Human Pre-designed siRNA Set A contains three designed siRNAs for MPP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MPP3 Human Pre-designed siRNA Set A contains three designed siRNAs for MPP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MPP4 Human Pre-designed siRNA Set A contains three designed siRNAs for MPP4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MPP7 Human Pre-designed siRNA Set A contains three designed siRNAs for MPP7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MPPED1 Human Pre-designed siRNA Set A contains three designed siRNAs for MPPED1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MPPED2 Human Pre-designed siRNA Set A contains three designed siRNAs for MPPED2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MPRIP Human Pre-designed siRNA Set A contains three designed siRNAs for MPRIP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Mpro/Cathepsin L-IN-1 (Compound 4d) is a SARS-CoV-2 Mpro/hCatL inhibitor, with Kis of 5.54 μM and 0.701 μM respectively[1].

MPST Human Pre-designed siRNA Set A contains three designed siRNAs for MPST gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MPV17 Human Pre-designed siRNA Set A contains three designed siRNAs for MPV17 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MPV17L Human Pre-designed siRNA Set A contains three designed siRNAs for MPV17L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MPX-007 is a GluN2A antagonist (IC50: 27 nM). MPX-007 is a tools to probe GluN2A physiology, and to study neuropsychiatric and developmental disorders[1].

MPZ Human Pre-designed siRNA Set A contains three designed siRNAs for MPZ gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MPZL1 Human Pre-designed siRNA Set A contains three designed siRNAs for MPZL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MPZL2 Human Pre-designed siRNA Set A contains three designed siRNAs for MPZL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MPZL3 Human Pre-designed siRNA Set A contains three designed siRNAs for MPZL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MQA-P is a multifunctional near-infrared (NIR) fluorescent probe that simultaneously detects ONOO–, viscosity, and polarity within mitochondria. MQA-P exhibits significant response to ONOO–, λem=645 nm; and NIR channel at λem>704 nm Medium is highly sensitive to viscosity/polarity. MQA-P possesses excited-state intramolecular charge transfer (ESICT) properties that are highly sensitive to polarity by designing the N,N-dimethylamino […]

MQA-P is a multifunctional near-infrared (NIR) fluorescent probe that simultaneously detects ONOO–, viscosity, and polarity within mitochondria. MQA-P exhibits significant response to ONOO–, λem=645 nm; and NIR channel at λem>704 nm Medium is highly sensitive to viscosity/polarity. MQA-P possesses excited-state intramolecular charge transfer (ESICT) properties that are highly sensitive to polarity by designing the N,N-dimethylamino […]

MQA-P is a multifunctional near-infrared (NIR) fluorescent probe that simultaneously detects ONOO–, viscosity, and polarity within mitochondria. MQA-P exhibits significant response to ONOO–, λem=645 nm; and NIR channel at λem>704 nm Medium is highly sensitive to viscosity/polarity. MQA-P possesses excited-state intramolecular charge transfer (ESICT) properties that are highly sensitive to polarity by designing the N,N-dimethylamino […]

MR-2-93-3 is a long-chain fatty acid that can be used to deliver polynucleotides[1].

MR1 Human Pre-designed siRNA Set A contains three designed siRNAs for MR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MR24, a G-5555 (HY-19635) derivative, is a mammalian STE20-like (MST) kinase inhibitor. MR24 selectively target MST3/4, with EC50 values of 57 and 583 nM, respectively[1].

MRAP Human Pre-designed siRNA Set A contains three designed siRNAs for MRAP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MRAP2 Human Pre-designed siRNA Set A contains three designed siRNAs for MRAP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.